Loading...
 

Volume 34, Issue 4, December 2023



Sign in to download the Issue in PDF format.

Mediterr J Rheumatol 2022;33(3):361-7
Fever of Unknown Origin and Hepatitis as the Initial Presentation of Anti-MDA-5 Positive Dermatomyositis: A Case Report
Authors Information
  1. Department of Internal Medicine, Military Hospital, Ambala, Haryana, India
  2. Department of Rheumatology, Command Hospital Southern Command, Pune, Maharashtra, India
  3. Department of Internal Medicine, Armed Forces Medical College, Pune, Maharashtra, India
References
  1. L  Attard, M  Tadolini, D U  De Rose, M  Cattalini. Overview of fever of unknown origin in adult and paediatric patients. Clin Exp Rheumatol 2018;36 (Suppl. 110):S10-S24.
  2. Naito T, Tanei M, Ikeda N, Ishii T, Suzuki T, Morita H, et al. Key diagnostic characteristics of fever of unknown origin in Japanese patients: a prospective multicentre study. BMJ Open 2019;9:e032059.
  3. 3.      Rupali P, Garg D, Viggweswarupu S, Sudarsanam T D, Jeyaseelan V, Abraham OC. Etiology of Classic Fever of Unknown Origin (FUO) among Immunocompetent Indian Adults. J Assoc Physicians India 2019;67:21-6.
  4. Bandyopadhyay D, Bandyopadhyay R, Paul R, Roy D. Etiological study of Fever of unknown origin in patients admitted to medicine ward of a teaching hospital of eastern India. J Glob Infect Dis 2011;3:329-33.
  5. Cobos GA, Femia A, Vleugels RA. Dermatomyositis: An Update on Diagnosis and Treatment. Am J Clin Dermatol 2020;21:339-53.
  6. Zhou G, Zhou Y, Zhong C, Ye H, Liu Z, Liu Y, et al. Retrospective analysis of 1,641 cases of classic fever of unknown origin. Ann Transl Med 2020;8:690.
  7. Lee LW, Narang NS, Postolova A, Seminara N, Kantor MA. Anti-MDA5-Positive Dermatomyositis Presenting as Fever of Unknown Origin. J Gen Intern Med 2016;31:1530-36.
  8. Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 2005;52:1571-6.
  9. Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol 2011;65:25-34.
  10. Hamaguchi Y, Kuwana M, Hoshino K, Hasegawa M, Kaji K, Matsushita T, et al. Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Arch Dermatol 2011;147:391-8.
  11. Kurtzman DJB, Vleugels RA. Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: A concise review with an emphasis on distinctive clinical features. J Am Acad Dermatol 2018;78:776-85.
  12. Bachmeyer C, Tillie-Leblond I, Lacert A, Cadranel J, Aractingi S. "Mechanic's hands": a misleading cutaneous sign of the antisynthetase syndrome. Br J Dermatol 2007;156:192-4.
  13. Cao H, Pan M, Kang Y, Xia Q, Li X, Zhao X, et al. Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody. Arthritis Care Res (Hoboken) 2012;64:1602-10.
  14. Moghadam-Kia S, Oddis CV, Sato S, Kuwana M, Aggarwal R. Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis. J Rheumatol 2017;44:319-25.
  15. Ceribelli A, Fredi M, Taraborelli M, Cavazzana I, Tincani A, Selmi C, et al. Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis. Clin Exp Rheumatol 2014;32:891-7.
  16. Koga T, Fujikawa K, Horai Y, Okada A, Kawashiri SY, Iwamoto N, et al. The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM. Rheumatology (Oxford) 2012;51(7):1278-84.
  17. Takahashi A, Abe K, Yokokawa J, Iwadate H, Kobayashi H, Watanabe H, et al. Clinical features of liver dysfunction in collagen diseases. Hepatol Res 2010;40:1092-7.
  18. Wada T, Abe G, Kudou T, Ogawa E, Nagai T, Tanaka S, Hirohata S. Liver damage in patients with polymyositis and dermatomyositis. Kitasato Med J 2016;46:40-6.
  19. Gono T, Kawaguchi Y, Ozeki E, Ota Y, Satoh T, Kuwana M, et al. Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis. Mod Rheumatol 2011;21:223-7.